Hazem M Elderiny, Yomna S Khallaf, Mai M Akah, Olfat E Hassanein
{"title":"生物活性注射树脂复合材料与传统纳米复合材料在后牙体修复中的临床评价：一项为期18个月的随机对照临床试验。","authors":"Hazem M Elderiny, Yomna S Khallaf, Mai M Akah, Olfat E Hassanein","doi":"10.5005/jp-journals-10024-3737","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the clinical performance of bioactive injectable resin composite vs nanohybrid resin composite in restoring carious posterior teeth.</p><p><strong>Materials and methods: </strong>A total of 18 patients with 26 class I and II carious cavities were recruited. Teeth were divided into two groups (<i>n</i> = 13): group I: Bioactive injectable resin composite (Beautifil Flow Plus X F00) while group II: Nanohybrid resin composite (Tetric N-Ceram) and were restored according to the manufacturer's instructions. The restorations were evaluated using the modified USPHS criteria at baseline, 6, 12, and 18 months. Data were tabulated and statistically analyzed with a significant level set at (<i>p</i> ≤ 0.05). Using the Chi-squared test and Cochran's <i>Q</i> test. The survival rate was analyzed using the Kaplan-Meier and Log-rank tests.</p><p><strong>Results: </strong>Inter- and intra-group comparisons showed no statistically significant difference between bioactive injectable resin composite and nanohybrid resin composite at different time intervals in terms of anatomical form, marginal adaptation, secondary caries, marginal staining, postoperative sensitivity. Moreover, there was no statistically significant difference between both materials regarding the overall survival rate after 18 months.</p><p><strong>Conclusions: </strong>The clinical performance of bioactive injectable resin composite and nanohybrid resin composite was similar and found to be clinically acceptable after 18 months of clinical use.</p><p><strong>Clinical significance: </strong>Bioactive injectable resin composite can be used to restore occlusal anatomy as a nanohybrid resin composite in restoring posterior cavities with acceptable clinical performance.</p><p><strong>Trial registration: </strong>It was registered in (www.</p><p><strong>Clinicaltrials: </strong>gov) database in June 2022, with identification number NCT05499494. How to cite this article: Elderiny HM, Khallaf YS, Akah MM, et al. Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial. J Contemp Dent Pract 2024;25(8):794-802.</p>","PeriodicalId":35792,"journal":{"name":"Journal of Contemporary Dental Practice","volume":"25 8","pages":"794-802"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial.\",\"authors\":\"Hazem M Elderiny, Yomna S Khallaf, Mai M Akah, Olfat E Hassanein\",\"doi\":\"10.5005/jp-journals-10024-3737\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To evaluate the clinical performance of bioactive injectable resin composite vs nanohybrid resin composite in restoring carious posterior teeth.</p><p><strong>Materials and methods: </strong>A total of 18 patients with 26 class I and II carious cavities were recruited. Teeth were divided into two groups (<i>n</i> = 13): group I: Bioactive injectable resin composite (Beautifil Flow Plus X F00) while group II: Nanohybrid resin composite (Tetric N-Ceram) and were restored according to the manufacturer's instructions. The restorations were evaluated using the modified USPHS criteria at baseline, 6, 12, and 18 months. Data were tabulated and statistically analyzed with a significant level set at (<i>p</i> ≤ 0.05). Using the Chi-squared test and Cochran's <i>Q</i> test. The survival rate was analyzed using the Kaplan-Meier and Log-rank tests.</p><p><strong>Results: </strong>Inter- and intra-group comparisons showed no statistically significant difference between bioactive injectable resin composite and nanohybrid resin composite at different time intervals in terms of anatomical form, marginal adaptation, secondary caries, marginal staining, postoperative sensitivity. Moreover, there was no statistically significant difference between both materials regarding the overall survival rate after 18 months.</p><p><strong>Conclusions: </strong>The clinical performance of bioactive injectable resin composite and nanohybrid resin composite was similar and found to be clinically acceptable after 18 months of clinical use.</p><p><strong>Clinical significance: </strong>Bioactive injectable resin composite can be used to restore occlusal anatomy as a nanohybrid resin composite in restoring posterior cavities with acceptable clinical performance.</p><p><strong>Trial registration: </strong>It was registered in (www.</p><p><strong>Clinicaltrials: </strong>gov) database in June 2022, with identification number NCT05499494. How to cite this article: Elderiny HM, Khallaf YS, Akah MM, et al. Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial. J Contemp Dent Pract 2024;25(8):794-802.</p>\",\"PeriodicalId\":35792,\"journal\":{\"name\":\"Journal of Contemporary Dental Practice\",\"volume\":\"25 8\",\"pages\":\"794-802\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Contemporary Dental Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/jp-journals-10024-3737\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Dentistry\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Contemporary Dental Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10024-3737","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0
摘要
目的：比较生物活性注射树脂复合材料与纳米复合树脂复合材料修复后牙龋病的临床效果。材料与方法：共18例ⅰ、ⅱ类龋齿26例。将牙齿分为两组（n = 13）：第一组：生物活性注射树脂复合材料（Beautifil Flow Plus X F00），第二组：纳米复合树脂复合材料（Tetric n - ceram），根据制造商的说明进行修复。在基线、6个月、12个月和18个月使用改良的USPHS标准对修复体进行评估。将数据制成表格，以显著水平集（p≤0.05）进行统计学分析。使用卡方检验和科克伦Q检验。生存率分析采用Kaplan-Meier和Log-rank检验。结果：组间、组内比较，生物活性注射树脂复合材料与纳米杂化树脂复合材料在不同时间间隔的解剖形态、边缘适应、继发龋、边缘染色、术后敏感性差异均无统计学意义。此外，两种材料在18个月后的总生存率方面没有统计学上的显著差异。结论：生物活性注射树脂复合材料与纳米复合树脂复合材料临床性能相近，临床使用18个月后均可接受。临床意义：生物活性可注射树脂复合材料可作为纳米复合树脂复合材料修复后牙腔，临床表现良好，可用于修复咬合解剖。试验注册：于2022年6月在（www.Clinicaltrials: gov）数据库注册，识别号NCT05499494。如何引用本文：Elderiny HM， Khallaf YS， Akah MM等。生物活性注射树脂复合材料与传统纳米复合材料在后牙体修复中的临床评价：一项为期18个月的随机对照临床试验。[J]现代医学学报；2009;25(8):794-802。
Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial.
Aim: To evaluate the clinical performance of bioactive injectable resin composite vs nanohybrid resin composite in restoring carious posterior teeth.
Materials and methods: A total of 18 patients with 26 class I and II carious cavities were recruited. Teeth were divided into two groups (n = 13): group I: Bioactive injectable resin composite (Beautifil Flow Plus X F00) while group II: Nanohybrid resin composite (Tetric N-Ceram) and were restored according to the manufacturer's instructions. The restorations were evaluated using the modified USPHS criteria at baseline, 6, 12, and 18 months. Data were tabulated and statistically analyzed with a significant level set at (p ≤ 0.05). Using the Chi-squared test and Cochran's Q test. The survival rate was analyzed using the Kaplan-Meier and Log-rank tests.
Results: Inter- and intra-group comparisons showed no statistically significant difference between bioactive injectable resin composite and nanohybrid resin composite at different time intervals in terms of anatomical form, marginal adaptation, secondary caries, marginal staining, postoperative sensitivity. Moreover, there was no statistically significant difference between both materials regarding the overall survival rate after 18 months.
Conclusions: The clinical performance of bioactive injectable resin composite and nanohybrid resin composite was similar and found to be clinically acceptable after 18 months of clinical use.
Clinical significance: Bioactive injectable resin composite can be used to restore occlusal anatomy as a nanohybrid resin composite in restoring posterior cavities with acceptable clinical performance.
Trial registration: It was registered in (www.
Clinicaltrials: gov) database in June 2022, with identification number NCT05499494. How to cite this article: Elderiny HM, Khallaf YS, Akah MM, et al. Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial. J Contemp Dent Pract 2024;25(8):794-802.
期刊介绍：
The Journal of Contemporary Dental Practice (JCDP), is a peer-reviewed, open access MEDLINE indexed journal. The journal’s full text is available online at http://www.thejcdp.com. The journal allows free access (open access) to its contents. Articles with clinical relevance will be given preference for publication. The Journal publishes original research papers, review articles, rare and novel case reports, and clinical techniques. Manuscripts are invited from all specialties of dentistry i.e., conservative dentistry and endodontics, dentofacial orthopedics and orthodontics, oral medicine and radiology, oral pathology, oral surgery, orodental diseases, pediatric dentistry, implantology, periodontics, clinical aspects of public health dentistry, and prosthodontics.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
